Leader in
Scientific Marketing

Carsten Thiel

Carsten Thiel’s career within the realm of biomedicine, pharmaceutical marketing, and the medical sector spans many years, and touches upon various disciplines related to the field. This myriad of experiences, combined, has allowed Thiel to flourish within his field, and to become a leader in scientific marketing.

Born in Berlin, Thiel’s family lineage was rich with medical professionals, including his medic mother and father. Enthralled with DNA, and the concept of a pre-written manifest destiny for each individual, Thiel excelled throughout his education, setting the undoubtable path to remain within a not-yet-decided aspect of the medical field. Thiel initially pursued studies in Chemistry in his native country’s Malbrook, before exploring an Anglo-Saxon educational experience within the United Kingdom’s University of Bristol. Focused on the study of biochemistry, Thiel earned his Bachelor of Science degree, and forged ahead into post-undergraduate education.

Carsten Thiel attended the prestigious Max Planck Institute For Biophysical Chemistry, an elite research organization in Germany. Specializing in molecular biology, Thiel studied proteins involved in the morphing of healthy cells into cancerous cells. Thiel earned his PhD, and entered the workforce post-matriculation via the highly innovative pharmaceutical giant Hoffman la-Roche.

Early within his career as a Communications and Product Manager, Thiel parlayed his knowledge of scientific marketing, consumer culture, medical insight, and patient-first code of ethics into a swiftly rising career. Less than a year later, Thiel was provided with the vastly important duty of spearheading the initial product launch of the company’s first foray into the weight-loss sector, via new product Xenical. Thiel’s expertise, leadership style, and knowledge created a stellar initial launch for the product, with first year sales surpassing one billion Swiss francs. Most importantly, however, the product was well received within the mass market, and retained a positive consumer reputation.

After his initial foray into launching new products, Thiel excelled within this role throughout several years, launching many breakthrough innovations throughout various niche fields of the medical sector. Believing in the credo that these new treatments would assist thousands of patients, Thiel continuously sought ways to provide meaningful aid to all individuals through training prescribers, and ensuring unparallelled quality control standards.


CEO Spotlight: Carsten Thiel, Biopharmaceutical Expert and President of Europe at EUSA Pharma

CEOSpotlight: Carsten Thiel, Biopharmaceutical Expert and President of Europe at EUSA Pharma

Carsten Thiel is a biopharmaceutical expert with over 25 years experience in the commercial pharmaceutical industry. Holding a PhD in Molecular Biology and Biochemistry, he has contributed to countless medical advancements throughout his career, particularly in the fields of oncology and rare diseases.

Revealing Secrets through a Lifetime of Lessons with Carsten Thiel

Revealing Secrets through a Lifetime of Lessons with Carsten Thiel

Throughout the lengthy span of a professional career, countless hours are spent participating in a melee of activities, problem solving within extenuating circumstances, and developing the skills needed to excel in a variety of situations. Working professionals sometimes find themselves in unfamiliar territory, requiring critical thinking skills, intuitive action, and swift judgment to navigate the uncharted waters that are often associated with professional endeavors.

Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus

Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus

Carsten Thiel, President of European Commercialization, EUSA Pharma By CorpGov Staff In recent months, the Center for Disease Control and Prevention (CDC) announced the outbreak of a public health emergency of international concern – also known as the disease labeled COVID-19, or the Coronavirus. Coronaviruses

EUSA Pharma Names Industry Veterans to Newly Created Posts

EUSA Pharma names industry veterans to newly-created posts

UK and USA-based specialty drugmaker EUSA Pharma today announced the strengthening of its senior leadership… To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.